Reference answer · 340b-program · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · 340b-program

How do 340B covered entities document insulin dispensing eligibility and prevent duplicate discounts?

Covered entities must maintain real-time documentation proving each insulin prescription was for an eligible patient and dispensed through an authorized relationship. Compliance depends on accurate data links between EHRs, TPAs, and contract pharmacies to prevent duplicate discounts and meet HRSA’s audit expectations for traceable, contemporaneous records.